Milford, Mass. — Waters Corporation announced the global commercial launch of the BD FACSDiscover A7 Cell Analyzer, a spectral flow cytometry system designed for advanced cellular analysis in academic, pharmaceutical and contract research laboratories.
The system incorporates BD SpectralFX Technology and supports up to five lasers and 78 fluorescence detectors, enabling researchers to analyze more than 50 characteristics of a single cell.
Waters said the analyzer also includes FACSTruQ Technology for automated instrument calibration, setup and quality control. The company said the technology is designed to improve consistency across instruments, users and laboratory sites.
The FACSDiscover A7 also integrates BD FACSChorus Software with guided workflows and an autoloader intended to streamline experiments for both experienced and newer users.
“The FACSDiscover A7 Cell Analyzer lowers the barrier to advanced spectral flow cytometry and will open up new possibilities for immunology research, enabling our core facility to help scientists uncover deeper biological insights with greater standardization and confidence,” said Cheryl Kim, Senior Director, Flow Cytometry Core at the La Jolla Institute for Immunology.
Waters said the system achieved a coefficient of variation below 10% across a palette of more than 50 dyes, supporting reproducibility in high-parameter flow cytometry experiments.
“The FACSDiscover A7 Cell Analyzer couples advanced spectral performance and leading standardization with a compelling price-to-performance balance, bringing spectral flow cytometry within reach of more researchers than ever before, for applications from biomarker discovery to drug development,” said Steve Conly, Senior Vice President, Waters Biosciences at Waters Corporation.
The FACSDiscover A7 Cell Analyzer is commercially available globally and can be ordered through local Waters representatives.
